Bruker Corporation (BRKR)

NASDAQ: BRKR · USD

$62.0

+1.28 (+2.1%)· Recorded snapshot

Market cap	9.4B
Revenue (ttm)	3.5B
Net income (ttm)	-106.9M
EPS (ttm)	-$0.70
Shares out	152.4M
P/E (forward)	27.8x
Dividend	$0.20 (0.32%)
Volume	2,635,513
Beta	1.22

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 3.5B
Net income (ttm): -106.9M
EPS (ttm): -$0.70
P/E (forward): 27.8x
Market cap: 9.4B

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Aanhouden

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/E27.8

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROE-3

P25 n/aP50 n/aP75 n/a

ROIC7.6

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All BRKR indicators

Market & fundamental data

Available fields

263

Groups with data

Currency

USD

Showing 263 of 263 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	USD
CIK code	0001109354
Company name	Bruker Corporation
Country	United States
Country code	US
CUSIP number	116794108
Earnings date	2026-11-04
Earnings time	bmo
Employees	11,085
Employees change	-311
Employees growth	-2.73%
Enterprise value	$11.1B
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	1960
Industry	Medical Devices
IPO date	2000-08-04
Is primary listing	Yes
Is SPAC	No
ISIN number	US1167941087
Last 10-K release date	2026-02-27
Last earnings date	2026-08-04
Last refreshed	2026-10-28
Last stock split type	Never
Market cap	$9.4B
Market cap category	Mid-Cap
Next earnings date	2026-11-04
Options	Yes
Price	$62.02
Price currency	USD
Sector	Healthcare
SIC code	3826
Stock price date	2026-10-28
Symbol	BRKR
U.S. state	Massachusetts
Website	https://www.bruker.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Adjusted P/E ratio	33.71x
Average P/E ratio (10Y)	40.62x
Average P/E ratio (3Y)	47.87x
Average P/E ratio (5Y)	42.17x
Earnings yield	-1.13%
EV/EBIT	36.27x
EV/EBITDA	20.85x
EV/FCF	120.14x
EV/Sales	3.22x
FCF / EV yield	0.83%
FCF yield	0.98%
Forward EV/Sales	3.12x
Forward P/E	27.78x
Forward P/S	2.66x
Industry forward P/E	19.74x
Industry P/E	39.16x
P/(FCF - SBC) ratio	130.4x
P/(OCF - SBC) ratio	56.47x
P/B ratio	3.89x
P/FCF ratio	102.35x
P/OCF ratio	50.48x
P/S ratio	2.75x
PEG ratio	1.75x
Price / tangible book value	114.69x
Price/EBITDA ratio	17.76x
Sector forward P/E	23.56x
Sector P/E	50.08x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	8.89%
EBITDA margin	15.46%
FCF margin	2.68%
Gross margin	48.48%
Operating margin	8.89%
Pretax margin	-0.69%
Profit margin	-2.03%
Profit per employee	$-9,644
Revenue per employee	$315,706
ROA	3.14%
ROA (5Y)	6.28%
ROCE	6.41%
ROE	-3%
ROE (5Y)	18.91%
ROIC	7.6%
ROIC (5Y)	13.71%
SBC / revenue	0.58%
Tax / revenue	1.15%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth years	0
FCF growth	90.47%
FCF growth 3Y	-22.37%
FCF growth 5Y	-21.33%
Gross profit growth	0.56%
Gross profit growth (Q)	14.24%
Gross profit growth 3Y	6.56%
Gross profit growth 5Y	8.55%
Net income growth years	0
OCF growth	14.77%
OCF growth 10Y	-0.87%
OCF growth 3Y	-17.7%
OCF growth 5Y	-14.02%
Operating income growth	-9.14%
Operating income growth (Q)	176%
Operating income growth 3Y	-13.77%
Operating income growth 5Y	-4.46%
Revenue growth	1.65%
Revenue growth (Q)	5.15%
Revenue growth (QoQ)	1.83%
Revenue growth 10Y	8%
Revenue growth 3Y	8.84%
Revenue growth 5Y	9.1%
Revenue growth quarters	2
Revenue growth years	5

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	$-96.5M
Depreciation and amortization	$230.1M
EBIT	$311M
EBITDA	$541.1M
EPS	$-0.70
FCF per share	$0.62
Financing cash flow	$35.1M
Free cash flow	$93.9M
Free cash flow minus SBC	$73.7M
Gross profit	$1.7B
Income taxes	$40.4M
Investing cash flow	$-144.3M
Net borrowing	$-574.6M
Net cash flow	$92.9M
Net income	$-106.9M
Operating cash flow minus SBC	$170.2M
Operating income	$311M
Revenue	$3.5B
Stock-based compensation	$20.2M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	2.53
Book value per share	$15.63
Debt / EBITDA	3.1
Debt / equity	0.76
Debt / FCF	19.76
Goodwill	$1.4B
Interest coverage	5.06
Long-term assets	$3.8B
Long-term liabilities	$2.4B
Net cash (debt)	$-1.7B
Net cash / market cap	-17.38%
Net debt / EBITDA	3.09
Net debt / equity	0.69
Net debt / FCF	17.79
Piotroski F-Score	6
Property, plant and equipment	$714.1M
Shareholders' equity	$2.4B
Tangible book value	$83.8M
Tangible book value per share	$0.55
Total assets	$6.1B
Total cash	$184.9M
Total debt	$1.9B
Total liabilities	$3.6B
WACC	9.63%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.56
Current assets	$2.2B
Current liabilities	$1.2B
Current ratio	1.85
Inventory turnover	1.54
Net working capital	$875.9M
Quick ratio	0.8
Working capital	$1B
Working capital turnover	3.81

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-0.13%
Dividend growth	0%
Dividend growth (3Y)	0%
Dividend growth (5Y)	4.56%
Dividend growth years	0
Dividend payment date	2026-10-07
Dividend payment years	11
Dividend payout frequency	Quarterly
Dividend per share	$0.20
Dividend yield	0.32%
Ex-dividend date	2026-09-21
FCF payout ratio	32.45%
Last dividend	$0.05
Shareholder yield	0.19%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y price change	210.35%
10Y return CAGR	12.43%
10Y total return	222.69%
150-day SMA	$53.19
15Y price change	336.32%
15Y return CAGR	10.64%
15Y total return	355.84%
1D price change	2.11%
1M price change	-2.85%
1M total return	-2.85%
1W price change	11.48%
1W total return	11.48%
1Y price change	61.36%
1Y return CAGR	62.1%
1Y total return	62.05%
20-day SMA	$58.59
200-day SMA	$50.12
20Y price change	683.29%
20Y return CAGR	11.08%
20Y total return	718.34%
3M price change	3.83%
3M total return	3.92%
3Y price change	8.7%
3Y return CAGR	3.23%
3Y total return	10%
50-day SMA	$58.89
50-day SMA vs 200-day SMA	50over200
52-week high	$66.98
52-week high date	2026-09-30
52-week low	$32.37
52-week low date	2026-03-16
5Y price change	-19.6%
5Y return CAGR	-3.93%
5Y total return	-18.17%
6M price change	70.68%
6M total return	70.97%
All-time high	$94.86
All-time high date	2024-03-21
All-time low	$2.59
All-time low date	2003-03-12
Average true range (ATR)	$2.91
Average volume	2.2M
Beta (1Y)	1.26
Beta (2Y)	1.16
Beta (5Y)	1.22
Change from 52-week high	-7.41%
Change from 52-week low	91.63%
Change from all-time high	-34.27%
Change from all-time low	2,307.34%
Change from open	1.34%
Day's gap	0.76%
Dollar volume	$163.5M
High price	$63.28
Low price	$61.05
Monthly RSI	56.66
Open price	$61.20
Position in 52-week range	43.5%
Premarket change	-0.4%
Premarket close	$60.74
Premarket price	$60.50
Premarket volume	311
Previous close	$60.74
Price vs 150-day SMA	16.61%
Price vs 20-day SMA	5.86%
Price vs 200-day SMA	23.74%
Price vs 50-day SMA	5.31%
Relative volume	1.2
RSI	58.83
Sharpe ratio	1.06
Sharpe ratio (3Y)	0.2
Sharpe ratio (5Y)	0.03
Sortino ratio	1.68
Sortino ratio (3Y)	0.41
Sortino ratio (5Y)	0.18
Volume	2.6M
Weekly RSI	57.36
YTD price change	32.35%
YTD total return	32.77%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	103.7M
Float percentage	68.05%
Shares change (QoQ)	-0.26%
Shares change (YoY)	0.13%
Shares held by insiders	31.89%
Shares held by institutions	94.95%
Shares outstanding	152.4M
Short % of float	11.97%
Short % of shares	8.14%
Short ratio	5.5 days

Deeper analysis on BRKR

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this BRKR report

Is a complete BRKR research report available?

No complete published report is available for Bruker Corporation (BRKR) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Bruker Corporation (BRKR)

Price

Financial snapshot

Fair-value bridge

Latest news · BRKR

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All BRKR indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on BRKR

Frequently asked questions